BeStock  
Stocks › Biotechnology › TRAX

First Tracks Biotherapeutics TRAX

US equityMarket cap rank #2772Biotechnology
$41.64 −$2.82 (-6.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $40.70 -2.26%
Open$43.99
Prev close$44.46
Day range$41.23 – $44.74
Volume504.4K
Market cap$1.75B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts10
Average target$75.40+81.1% vs. price
  • Buy 100%
Low $57.00Now $41.64Avg $75.40High $110.00

Recent rating changes

The last 20 actions on file set price targets from $50.00 to $110.00, averaging $76.68.

DateFirmRatingTarget
12 Nov 2026 J.P. Morgan BUY $70.00
5 Nov 2026 CCORF BUY $57.00
5 Nov 2026 Leerink Partners BUY $90.00
4 Nov 2026 Wells Fargo BUY $70.00
4 Nov 2026 Piper Sandler BUY $95.00
4 Nov 2026 Wedbush BUY $70.00
4 Nov 2026 Barclays BUY $65.00
3 Nov 2026 Guggenheim BUY $110.00
20 Oct 2026 Piper Sandler BUY $95.00
19 Oct 2026 Leerink Partners BUY $90.00
16 Oct 2026 Leerink Partners BUY $90.00
13 Oct 2026 CCORF BUY $60.00
13 Oct 2026 Wells Fargo BUY $70.00
13 Oct 2026 Wedbush BUY $70.00
13 Oct 2026 Evercore BUY $70.00
13 Oct 2026 Barclays BUY $65.00
12 Oct 2026 Wells Fargo BUY $70.00
12 Oct 2026 Guggenheim BUY $100.00
12 Oct 2026 J.P. Morgan BUY –
9 Oct 2026 CCORF BUY $50.00

Discussion

No comments yet — be the first to weigh in on TRAX.

Sign in to join the discussion.

Scroll to Top